XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss     $ (1,564,000) $ (3,984,000)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and amortization     1,168,000 1,103,000  
Loss on disposal or impairment of long-lived assets     4,000 147,000  
Stock-based compensation expense     1,858,000 2,149,000  
Amortization of deferred commissions $ 6,000 $ 17,000 16,000 36,000  
Amortization of debt discount and issuance costs     47,000    
Amortization of right of use assets     137,000 199,000  
Change in fair value of contingent consideration     (12,000) 214,000  
Provision for accounts receivable     111,000 (1,000)  
Changes in operating assets and liabilities:          
Accounts receivable     (703,000) 739,000  
Prepaid expenses and other assets     (372,000) 119,000  
Accounts payable and accruals     (447,000) (82,000)  
Operating lease liability     (199,000) (271,000)  
Deferred revenue     569,000 (559,000)  
Net cash provided by (used in) operating activities     613,000 (191,000)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of equipment     (75,000) (57,000)  
Software development costs     (947,000) (999,000)  
Patent costs     (13,000)    
Net cash used in investing activities     (1,035,000) (1,056,000)  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from common stock offering, net of transaction costs     663,000    
Proceeds from employee stock purchase plan     53,000 36,000  
Payments related to settlement of employee shared-based awards     (744,000) (446,000)  
Settlement of contingent consideration     (1,677,000) (908,000)  
Repurchase of common stock     (2,016,000)    
Repayments of finance leases     (7,000) (22,000)  
Net cash used in financing activities     (3,728,000) (1,340,000)  
Net decrease in cash     (4,150,000) (2,587,000)  
Cash-beginning of period     9,236,000 6,904,000 $ 6,904,000
Cash-end of period $ 5,086,000 $ 4,317,000 5,086,000 $ 4,317,000 $ 9,236,000
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Common stock offering costs included in accounts payable     $ 100,000